期刊文献+

卵巢癌血管生成拟态的临床意义及HIF-1α、MMP-2表达 被引量:4

Clinical significance of vasculogenic mimicry and expressions of HIF-1α and MMP-2 in patients with ovarian carcinoma
原文传递
导出
摘要 目的:探讨卵巢癌血管生成拟态的临床意义及血管生成拟态与缺氧诱导因子HIF-1α、基质金属蛋白酶MMP-2表达的关系。方法:收集南通大学附属医院2000年1月~2009年5月问经手术切除的卵巢肿瘤组织石蜡标本81例,采用CD34和PAS双重染色方法证实卵巢癌组织中存在VM,探讨卵巢癌组织中VM与卵巢癌组织类型、病理分级、临床分期、肿瘤指标、患者生存时间的相关性,及VM与HIF-1α、MMP-2表达的关系。结果:卵巢癌中出现VM的几率要明显高于交界性卵巢肿瘤;低分化卵巢癌VM发生的几率要高于高分化的卵巢癌;Kaplan—Meier生存分析提示卵巢癌中存在VM的患者生存时间比无VM患者短。VM与HIF—1α蛋白、MMP-2蛋白表达相关。结论:具有血管生成拟态的卵巢癌组织分化低,患者临床预后差;HIF-1α、MMP-2表达与卵巢癌血管生成拟态密切相关。 Objective: To explore the clinical significance of vasculogenic mimicry in patients with ovarian carcinoma and the rela- tionship between vasculogenic mimicry and hypoxia induced factor - 1 α ( HIF - 1 α), matrix metalloproteinase - 2 ( MMP - 2 ) . Methods: 81 paraffin - embedded specimens of ovarian carcinoma after surgical resection in the hospital from January 2000 to May 2009 were collected, CD34 and PAS double staining methods were used to confirm that vasculogenic mimicry existed in ovarian carcinoma, the correlation between vasculogenic mimicry and histological types, pathological grades, clinical stages, tumor markers and survival time was explored, and the re- lationship between vasculogenic mimicry and expressions of HIF - 1 α and MMP2. Results : The rate of vasculogenic mimicry in ovarian carcinoma was significantly higher than that in borderline ovarian carcinoma ; the rate of vasculogenic mimicry in low differentiated ovarian carcinoma was significantly higher than that in high differentiated ovarian carcinoma; Kaplan - Meier survival analysis showed that the survival time in patients with vasculogenic mimicry was shorter than that in patients without vasculogenic mimicry ; vasculogenic mimicry was related to expressions of HIF - 1 α and MMP2. Conclusion : The prognosis of patients with vasculogenic mimicry and low differentiated ovarian carci- noma is poor; the expressions of HIF-1α and MMP2 are related to vasculogenic mimicry.
出处 《中国妇幼保健》 CAS 北大核心 2010年第33期4901-4905,共5页 Maternal and Child Health Care of China
基金 国家自然科学基金青年基金资助课题〔30801226〕 南通市社会发展科技计划资助课题〔S2008059〕
关键词 卵巢癌 血管生成拟态 HIF-1Α MMP-2 Ovarian carcinoma Vasculogenic mimicry Hypoxia induced factor - 1 α Matrix metalloproteinase - 2
  • 相关文献

参考文献10

  • 1曹泽毅,主编.妇产科学[M].北京:人民卫生出版社.2008:21.
  • 2Maniotis A J, Folberg R, Hess A et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry [J] . Am JPathol, 1999, 155:739.
  • 3Scavelli C, Nico B, Cirulli T et al. Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma [J] . Oncogene, 2008, 27 (5): 663.
  • 4Sun B, Zhang S, Zhang D et al. Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma [ J ] . Oncology Reports, 2006, 16 (4) : 693.
  • 5韩义明,王静,王国平,敖启林.肺癌组织中血管生成拟态和HIF-1α的表达及意义[J].临床与实验病理学杂志,2008,24(3):269-272. 被引量:15
  • 6Min Su, Liang - Qing Yao, You - Ji Feng et al. Plasticity of ovarian cancer cell and vasculogenic mimicry in vivo[J] . Int J Gynecol Cancer, 2008, 18:476.
  • 7薛惠荣,崔满华,于晓艳.HIF-1α在卵巢上皮性肿瘤组织中的表达及意义[J].中国妇幼保健,2008,23(6):857-858. 被引量:3
  • 8Garimella, Phani M, Wellman et al. Cytokine regulation of HIF - 1 alpha in ovarian cancer [J] . Proceedings of the American Association for Cancer Research Annual Meeting, 2006, 47:438.
  • 9Anil KS, MaviseS, Fletcher MD et al. Functional role of matrix metalloproteinases in ovarian tumor cell plasticity [ J]. Am J Obstet Gynecol, 2004, 190 (4): 899.
  • 10苏敏,丰有吉,黄妍,赵宇清.舒林酸对卵巢癌裸鼠腹腔移植瘤生长的影响[J].中国妇幼保健,2009,24(36):5197-5199. 被引量:1

二级参考文献26

  • 1赵秀兰,杜静,张诗武,刘易欣,王欣,孙保存.肝细胞肝癌中血管生成拟态的研究[J].中华肝脏病杂志,2006,14(1):41-44. 被引量:42
  • 2郝静,王秀问,孙殿水,李蓓,蔡毅然.非小细胞肺癌中HIF-1α、GLUT1与COX-2表达的关系[J].临床与实验病理学杂志,2006,22(2):191-193. 被引量:3
  • 3周蕾,于东红,王萍,承泽农.舒林酸对胃癌细胞株BGC-823作用的实验研究[J].蚌埠医学院学报,2007,32(2):132-135. 被引量:3
  • 4Yasuhisa Oida, Began Gopalan, Ryo Miyahara, et al. Sulindac enhances adenoviral vector expressing mda - 7/IL - 24 - mediated apoptosis in human lung cancer [ J] . Mol Cancer Ther, 2005, 4:291.
  • 5Lee HC, Park IC, Park MJ, et al. Sulindac and its metabolites inhibit invasion of glioblastoma cells via down - regulation of Akt/PKB and MMP-2[J]. Journal of Cellular Biochemistry, 2005, 94 (3) : 597.
  • 6Michele T, Yip- Schneider, Huangbing WU, et al. Suppression of pancreatic tumor growth by combination chemotherapy with sulindac and LC - 1 is associated with cyclin D1 inhibition in vivo [ J] . Mol Cancer Ther, 2007, 6:1736.
  • 7Yamamoto A, Yano S, Shiraga M,et al. A third -generation matrix metal- loproteinase (MMP) inhibitor ( ONO - 4817) combined with docetaxel suppresses progression of lung micrometastasis of MMP - expressing tumor cells in nude mice [J]. Int J Cancer,2003,103 (6) : 822.
  • 8Schumacker PT, Paul T. Hypoxia - inducible factor - 1. Crit Care Med, 2005, 33 (12Supp 1) : S423 -425
  • 9Jubb A, Hillan K. Expression of HIF - 1 alpha in human tumours. J Clin Pathol, 2005, 58 (3): 335-336
  • 10Kitada T, Seki S, Sakaguchi H, et al. Clinicopathological significance of hypoxia - inducible factor - 1 alpha expression in human pancreatic carcinoma. Histopathology, 2003, 43 (6) : 550

共引文献135

同被引文献29

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部